Altrinsic Global Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $194M | Sell |
2,242,374
-241,796
| -10% | -$23.2M | 6.96% | 6 |
|
|
2025
Q4 | $239M | Sell |
2,484,170
-118,892
| -5% | -$11.5M | 8.55% | 3 |
|
|
2025
Q3 | $248M | Sell |
2,603,062
-85,272
| -3% | -$7.84M | 9.17% | 3 |
|
|
2025
Q2 | $234M | Buy |
2,688,334
+868,256
| +48% | +$73.6M | 8.48% | 4 |
|
|
2025
Q1 | $164M | Sell |
1,820,078
-107,468
| -6% | -$9.62M | 8.07% | 5 |
|
|
2024
Q4 | $154M | Sell |
1,927,546
-28,155
| -1% | -$2.44M | 7.45% | 5 |
|
|
2024
Q3 | $176M | Sell |
1,955,701
-56,288
| -3% | -$4.74M | 7.49% | 4 |
|
|
2024
Q2 | $158M | Sell |
2,011,989
-177,941
| -8% | -$14.6M | 7.06% | 5 |
|
|
2024
Q1 | $191M | Sell |
2,189,930
-135,602
| -6% | -$11.6M | 8.61% | 4 |
|
|
2023
Q4 | $192M | Sell |
2,325,532
-133,754
| -5% | -$10.2M | 8.13% | 5 |
|
|
2023
Q3 | $193M | Sell |
2,459,286
-91,587
| -4% | -$7.67M | 7.44% | 5 |
|
|
2023
Q2 | $225M | Sell |
2,550,873
-46,116
| -2% | -$3.97M | 8.61% | 4 |
|
|
2023
Q1 | $209M | Buy |
2,596,989
+277,046
| +12% | +$22.6M | 8.11% | 4 |
|
|
2022
Q4 | $180M | Sell |
2,319,943
-103,607
| -4% | -$8.4M | 7.7% | 5 |
|
|
2022
Q3 | $196M | Buy |
2,423,550
+9,717
| +0.4% | +$873K | 9.01% | 4 |
|
|
2022
Q2 | $217M | Buy |
2,413,833
+377,823
| +19% | +$38.3M | 8.8% | 4 |
|
|
2022
Q1 | $226M | Buy |
2,036,010
+443,163
| +28% | +$46.8M | 7.9% | 4 |
|
|
2021
Q4 | $165M | Buy |
1,592,847
+292,720
| +23% | +$33.9M | 5.26% | 6 |
|
|
2021
Q3 | $163M | Buy |
1,300,127
+16,693
| +1% | +$2.16M | 4.88% | 8 |
|
|
2021
Q2 | $159M | Buy |
1,283,434
+82,944
| +7% | +$10.4M | 4.85% | 7 |
|
|
2021
Q1 | $142M | Buy |
1,200,490
+73,407
| +7% | +$8.6M | 4.47% | 7 |
|
|
2020
Q4 | $132M | Buy |
1,127,083
+48,781
| +5% | +$5.37M | 4.48% | 7 |
|
|
2020
Q3 | $112M | Buy |
1,078,302
+25,103
| +2% | +$2.52M | 4.59% | 6 |
|
|
2020
Q2 | $96.6M | Buy |
1,053,199
+53,060
| +5% | +$5.09M | 4.21% | 8 |
|
|
2020
Q1 | $90.2M | Buy |
1,000,139
+49,811
| +5% | +$5.3M | 4.97% | 6 |
|
|
2019
Q4 | $108M | Sell |
950,328
-12,739
| -1% | -$1.4M | 4.53% | 7 |
|
|
2019
Q3 | $105M | Sell |
963,067
-445,358
| -32% | -$46.5M | 4.53% | 5 |
|
|
2019
Q2 | $137M | Buy |
1,408,425
+385,703
| +38% | +$35.2M | 6.35% | 4 |
|
|
2019
Q1 | $93.2M | Sell |
1,022,722
-9,216
| -0.9% | -$825K | 4.3% | 7 |
|
|
2018
Q4 | $93.9M | Sell |
1,031,938
-549,693
| -35% | -$51.4M | 4.5% | 6 |
|
|
2018
Q3 | $156M | Sell |
1,581,631
-131,606
| -8% | -$12.2M | 7.04% | 3 |
|
|
2018
Q2 | $147M | Buy |
1,713,237
+8,268
| +0.5% | +$691K | 5.79% | 4 |
|
|
2018
Q1 | $137M | Sell |
1,704,969
-14,526
| -0.8% | -$1.2M | 5.52% | 6 |
|
|
2017
Q4 | $139M | Sell |
1,719,495
-10,931
| -0.6% | -$875K | 5.33% | 6 |
|
|
2017
Q3 | $135M | Buy |
1,730,426
+749,261
| +76% | +$62.2M | 5.09% | 5 |
|
|
2017
Q2 | $87.1M | Sell |
981,165
-83,601
| -8% | -$7.05M | 3.15% | 9 |
|
|
2017
Q1 | $85.8M | Sell |
1,064,766
-5,858
| -0.5% | -$458K | 2.91% | 9 |
|
|
2016
Q4 | $76.3M | Sell |
1,070,624
-65,529
| -6% | -$5.15M | 2.83% | 10 |
|
|
2016
Q3 | $98.2M | Sell |
1,136,153
-165,646
| -13% | -$14.4M | 3.59% | 6 |
|
|
2016
Q2 | $113M | Sell |
1,301,799
-260,897
| -17% | -$21.1M | 3.19% | 8 |
|
|
2016
Q1 | $117M | Sell |
1,562,696
-15,944
| -1% | -$1.2M | 3.28% | 7 |
|
|
2015
Q4 | $121M | Sell |
1,578,640
-83,295
| -5% | -$6.27M | 3.15% | 8 |
|
|
2015
Q3 | $111M | Sell |
1,661,935
-280,438
| -14% | -$20.7M | 2.58% | 12 |
|
|
2015
Q2 | $144M | Sell |
1,942,373
-254,682
| -12% | -$19.5M | 2.95% | 10 |
|
|
2015
Q1 | $171M | Buy |
+2,197,055
| New | +$167M | 3.72% | 6 |
|
Other funds holding MDT
VCM
VPM
Altrinsic Global Advisors's MDT Position: Q1 2026 in Review
Altrinsic Global Advisors reduced its Medtronic (MDT) stake by 9.7% in Q1 2026, selling an estimated $23.2M and leaving 2,242,374 shares worth $194M. The position accounts for 6.96% of the portfolio, ranked #6.
Altrinsic Global Advisors first reported a position in MDT in Q1 2015 and has held it in 45 quarters since. The position peaked at $248M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Altrinsic Global Advisors held 2,242,374 shares of Medtronic worth $194M as of Q1 2026.
- Altrinsic Global Advisors sold 241,796 Medtronic shares in Q1 2026, an estimated $23.2M.
- Medtronic made up 6.96% of Altrinsic Global Advisors's portfolio in Q1 2026, its #6 holding.
- Altrinsic Global Advisors first reported a position in Medtronic in Q1 2015 and has held it in 45 quarters since.
- Altrinsic Global Advisors's Medtronic position peaked at $248M in Q3 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Altrinsic Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.